1630815-44-9

Basic information

• Product Name: (3S,4R)-4-aminooxan-3-ol hydrochloride
• Synonyms: (3S,4R)-4-aminooxan-3-ol hydrochloride;(3S,4R)-4-Aminotetrahydro-2H-pyran-3-ol hydrochloride
• CAS NO: 1630815-44-9
• Molecular Weight: 0
• Mol File: 1630815-44-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (3S,4R)-4-aminooxan-3-ol hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: (3S,4R)-4-aminooxan-3-ol hydrochloride(1630815-44-9)
• EPA Substance Registry System: (3S,4R)-4-aminooxan-3-ol hydrochloride(1630815-44-9)

Safety Data

• Hazardous Substances Data: 1630815-44-9(Hazardous Substances Data)

Usage

General Description

(3S,4R)-4-aminooxan-3-ol hydrochloride is a chemical compound that has the molecular formula C3H9ClN2O2. It is a hydrochloride salt formed by the reaction of (3S,4R)-4-aminooxan-3-ol with hydrochloric acid. (3S,4R)-4-aminooxan-3-ol hydrochloride is a derivative of oxane, a six-membered ring with four carbon atoms and one oxygen atom. It is commonly used in organic synthesis and pharmaceutical research as a chiral building block. The hydrochloride salt form of (3S,4R)-4-aminooxan-3-ol enhances its solubility in water and makes it suitable for various applications in chemical and pharmaceutical industries.

Upstream product

• 1363380-59-9 trans-4-aminotetrahydro-2H-pyran-3-ol 
• 286-22-6 3,4-epoxytetrahydropyran 
• 3174-74-1 dihydropyran 
• 134419-59-3 4-oxanyl methanesulfonate 
• 2081-44-9 Tetrahydro-pyran-4-ol 

Relevant articles and documents

MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt (s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The present invention describes the preparation, pharmaceutical composition and the use of compound formula (I).

INDOL AND INDAZOL DERIVATIVES

The present invention relates to indole and indazole derivatives of the following formula (I) wherein A is (AA) and the remaining variables are as defined in the specification. The compounds may be used for the treatment or prophylaxis of Alzheimer's disease, cognitive impairment, schizophrenia, pain or sleep disorders.

Protease inhibitors

The invention relates to 3-hydroxy-and 3-keto-cyclohetero-substituted leucine compounds that are inhibitors of cysteine proteases, particularly cathepsin K, and are useful in the treatment of diseases in which inhibition of bone loss is a factor. The 3-hydroxy-or 3-keto-moiety is bonded to a tetrahydrothiophene, tetrahydrothiopyran, tetrahydrofuran or tetrahydropyran ring.